pyrimidine has been researched along with digoxin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrego, J; Asara, JM; Attri, KS; Augustine, JJ; Berim, L; Cantley, LC; Chaika, NV; Dai, B; Dasgupta, A; Fleming, JB; Gebregiworgis, T; Goode, GD; Grandgenett, PM; Grem, JL; Gunda, V; Hankins, JH; Hollingsworth, MA; Illies, AL; Kim, JW; King, RJ; Lazenby, AJ; Ly, QP; Lyssiotis, CA; Mashadova, O; Matés, JM; Mehla, K; Murthy, D; Oliveto, JM; Powers, R; Purohit, V; Sasson, AR; Serkova, NJ; Shukla, SK; Singh, PK; Vernucci, E; Weekes, C; Yu, F | 1 |
1 other study(ies) available for pyrimidine and digoxin
| Article | Year |
|---|---|
MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer.
Topics: Carbon; Deoxycytidine; Digoxin; Drug Resistance, Neoplasm; Gemcitabine; Glucose; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mucin-1; Pancreatic Neoplasms; Pentose Phosphate Pathway; Prognosis; Pyrimidines; Signal Transduction | 2017 |